ライフサイエンスコーパス: cardiomyoplasty

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 potential off-the-shelf product for cellular cardiomyoplasty.

2 unity to refine approaches used for cellular cardiomyoplasty.

3 or using these adult stem cells for cellular cardiomyoplasty.

4 Eight dogs were randomly selected to undergo cardiomyoplasty.

5 critical to enhance the efficacy of cellular cardiomyoplasty.

6 are in phase 1 clinical studies of cellular cardiomyoplasty.

7 ffer several new insights regarding cellular cardiomyoplasty.

8 then randomly selected to undergo subsequent cardiomyoplasty, and all dogs had 6 weeks of additional

9 partial left ventricular resection, dynamic cardiomyoplasty, and left ventricular assist devices.

10 ndoventricular patch plasty (Dor procedure), cardiomyoplasty, and prosthetic external constraints are

11 e systolic assistance, benefits from dynamic cardiomyoplasty appear to be partially accounted for by

12 The evaluation of stem cell-mediated cardiomyoplasty by noninvasive in vivo imaging is critic

13 ation of myocardial energetics after dynamic cardiomyoplasty (CMP) in a model of left ventricular (LV

14 cardial oxygen consumption (MVo2) in dynamic cardiomyoplasty (DCM), previous studies have calculated

15 onduits, generation of heart valve leaflets, cardiomyoplasty, genetic manipulation, and in vitro cond

16 The cardiomyoplasty group also received 6 weeks of concurren

17 ar end-diastolic pressures stabilized in the cardiomyoplasty group but continued to deteriorate in co

18 tward in controls but remained stable in the cardiomyoplasty group.

19 Dynamic cardiomyoplasty has been in use for 12 years.

20 Cellular cardiomyoplasty has been proposed as an alternative stra

21 Cellular cardiomyoplasty has emerged as a novel therapy to restor

22 onal precursors, cardiospheres, for cellular cardiomyoplasty in a mini-pig model of heart failure aft

23 Dynamic cardiomyoplasty is a promising new therapy for dilated c

24 normal functional capacity and that cellular cardiomyoplasty is hampered by poor survival, proliferat

25 ization, mitral valve repair or replacement, cardiomyoplasty, left ventricular volume reduction surge

26 class that occurs in patients after dynamic cardiomyoplasty may be secondary to its beneficial effec

27 the LD and myocardium in a balloon-mediated cardiomyoplasty procedure in five goats.

28 Stem cell-based cellular cardiomyoplasty represents a promising therapy for myoca

29 s a biomaterial scaffold to improve cellular cardiomyoplasty treat and MIs.

30 Cardiomyoplasty with skeletal myoblasts may benefit card

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。